Correlation Between Dupont De and Galectin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Galectin Therapeutics, you can compare the effects of market volatilities on Dupont De and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Galectin Therapeutics.
Diversification Opportunities for Dupont De and Galectin Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dupont and Galectin is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Galectin Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Galectin Therapeutics
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to under-perform the Galectin Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dupont De Nemours is 2.16 times less risky than Galectin Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Galectin Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 275.00 in Galectin Therapeutics on August 30, 2024 and sell it today you would earn a total of 9.00 from holding Galectin Therapeutics or generate 3.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Galectin Therapeutics
Performance |
| Timeline |
| Dupont De Nemours |
| Galectin Therapeutics |
Dupont De and Galectin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Galectin Therapeutics
The main advantage of trading using opposite Dupont De and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.| Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide | Dupont De vs. LyondellBasell Industries NV |
| Galectin Therapeutics vs. Madrigal Pharmaceuticals | Galectin Therapeutics vs. Viking Therapeutics | Galectin Therapeutics vs. Sarepta Therapeutics | Galectin Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |